BIOSPECIFICS TECHNOLOGIES CORP 4/A
4/A · BIOSPECIFICS TECHNOLOGIES CORP · Filed Jun 22, 2015
Insider Transaction Report
Form 4/AAmended
Mattila Jyrki
Director
Transactions
- Award
Stock Option (Right to Buy)
2015-04-22+15,000→ 15,000 totalExercise: $37.64Exp: 2025-04-22→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The purpose of this Form 4/A is solely to correct the exercise price of derivative securities granted to the reporting person and does not represent any acquisition or disposition of shares by the reporting person.
- [F2]The options were granted on April 22, 2015 and will vest in four equal annual installments beginning on the first anniversary of the grant date.